Vulcan Energy has secured approval and building permits for the 30 megawatt (MW) geothermal renewable energy plant and ...

Bell Potter has placed a 'sell' rating on Cettire after the luxury retail platform missed earnings estimates on Thursday, ...

Australian shares are set to open higher after all three US indices closed higher overnight, spurred by a 13% jump by ...

The news: A Google Cloud outage took down multiple popular online services including Spotify, Discord, and Google, with tens ...

The government’s failure to act on AI is hurting productivity and living standards — Australia needs a clear, urgent strategy ...

A closely-watched US$22 billion ($33.7 billion) auction of 30-year US Treasury bonds drew solid demand, with investors ...

Chime Financial’s shares jumped as much as 66.4% in its trading debut after raising US$864 million ($1.32 billion) in an ...

Former iflix CEO Mark Britt has emerged from stealth mode with tmrw, an AI-driven preventive health platform which has ...

The sale of 23andMe's genetic database to Regeneron shows gaps in Australia's cross-border data protection laws for sensitive ...

The Los Angeles-based AI firm is in talks with Australian publishers after finalising deals with the men's publisher Man of ...

Plus: Trump says Israeli strike on Iran ‘could very well happen’; 30-year bond auction gets strong result, lower foreign ...

Clarity Pharmaceuticals has announced positive topline results from a phase two diagnostic trial, which found its cancer radiopharmaceutical Cu-SAR-Bombesin is effective in detecting prostate cancer ...